Stay updated on ARGX-113 Safety & Efficacy in Pemphigus Clinical Trial
Sign up to get notified when there's something new on the ARGX-113 Safety & Efficacy in Pemphigus Clinical Trial page.

Latest updates to the ARGX-113 Safety & Efficacy in Pemphigus Clinical Trial page
- Check6 days agoChange DetectedRevision: v3.4.3 replaces the previous v3.4.2.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.4.2 is now displayed on the site. The funding-lapse notice and the v3.4.1 revision entry have been removed.SummaryDifference0.4%

- Check41 days agoChange DetectedA system notice about a lapse in government funding and current operating status was added, and the page revision was updated to v3.4.1 (from v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check48 days agoChange DetectedThe page now displays a glossary and updated metadata, showing 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and revision 'v3.4.0'. These replace the previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and revision 'v3.3.4'.SummaryDifference0.2%

- Check62 days agoChange DetectedRevision: v3.3.4 replaces v3.3.3 on the page; no user-facing changes to study details or navigation are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedFooter now shows Revision: v3.3.3 and the HHS Vulnerability Disclosure link has been removed, replacing the prior reference to Revision: v3.3.2.SummaryDifference0.1%

Stay in the know with updates to ARGX-113 Safety & Efficacy in Pemphigus Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARGX-113 Safety & Efficacy in Pemphigus Clinical Trial page.